Abstract
We have previously shown that platelet-activating factor (PAF: l-O-alkyl-2-sn-3-glycerophosphocholine) selectively augments EPSCs in cultured hippocampal neurons by a presynaptic mechanism, suggesting that this agent could be involved in hippocampal long-term potentiation (LTP). We have also examined the possible involvement of PAF in LTP in the CA1 region of rat hippocampal slices using the hydrolysis resistant analog, methyl-carbamyl-PAF (C-PAF), and PAF receptor antagonists. When 2 μM BN--52021, a synaptosomal PAF receptor antagonist, was applied, LTP was inhibited and 20 min application of 1 μM MC-PAF in the absence of tetanic stimulation produced a slowly developing potentiation of extracellular recorded EPSP’s which persisted for more than 2h. Extra- or intracellular administration of C-PAF also appears to slow the washout of LTP-generating ability which occurs during whole-cell recording, making it possible to induce LTP for as long as 60 min after cell penetration. A decrease in extracellular magnesium (0.1 mM) for 15 min induced LTP which was not inhibited by a PAF antagonist, indicating the existence of PAF dependent and independent LTP. These data suggest that PAF and PAF activated process are important in LTP and modulate the threshold for LTP induction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Refferences
Clarke, D.G., Happel, L.T., Zorumski, C.F., and Bazan, N.G. 1992. Enhancement of hippocampal excitatory synaptic transmission by platelet-activating factor. Neuron92:1211–1216.
Cerro, S.del, Arai, A., and Lnch, G. 1990. Inhibition of long-term potentiation by an antagonist of platelet-activating factor. 54:213–217.
Kato, K., Clark, G.D., Bazan, N.G., and Zorumski, C.F. 1994. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature367:175–179.
Birkle, D.L., Kuiran, P., Braquet, P., and Bazan, N.G. 1988. Platelet-activating factor antagonist BN52021 decreases accumulation of free polysaturated fatty acid in mouse brain during ischemia and electroconvulsive shock. J. Neurochem.51(6):1900–1905.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kato, K. (1999). Modulation of Long-Term Potentiation in the CA1 Area of Rat Hippocampus by Platelet-Activating Factor. In: Honn, K.V., Marnett, L.J., Nigam, S., Dennis, E.A. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 4. Advances in Experimental Medicine and Biology, vol 469. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4793-8_33
Download citation
DOI: https://doi.org/10.1007/978-1-4615-4793-8_33
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7171-7
Online ISBN: 978-1-4615-4793-8
eBook Packages: Springer Book Archive